Clinical Trial Update: Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial update evaluating CHS-388 (formerly SRF388) in patients with advanced solid tumors, including clear cell renal cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• CHS-388

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma | Phase 1 | Status: COMPLETED